BMS 200 mg 6672 (Videx EC 200 MG)
Generic Name: didanosine
Pill with imprint BMS 200 mg 6672 is White, Capsule-shape and has been identified as Videx EC 200 MG. It is supplied by Bristol-Myers Squibb.
Videx EC is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Videx EC 200 MG is not a controlled substance under the Controlled Substances Act (CSA).
Images for BMS 200 mg 6672
Videx EC
- Generic Name
- didanosine
- Imprint
- BMS 200 mg 6672
- Strength
- 200 MG
- Color
- White
- Size
- 18.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bristol-Myers Squibb
- National Drug Code (NDC)
- 00087-6672 (Discontinued)
- Inactive Ingredients
-
carboxymethylcellulose sodium,
diethyl phthalate,
methacrylic acid - methyl methacrylate copolymer (1:2),
sodium hydroxide,
sodium starch glycolate type A potato,
magnesium silicate,
gelatin,
titanium dioxide
Note: Inactive ingredients may vary.
More about Videx EC (didanosine)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Drug images
- En español
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
Patient resources
- Other brands
- Videx
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.